Anzeige
Mehr »
Freitag, 09.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
472 Leser
Artikel bewerten:
(2)

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the PFAS Testing Quadrant Report 2025

DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- 360Quadrants has released its latest PFAS testing Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and emerging innovators, for their excellence in market presence, product innovation, and business strategy. The report highlights Restek Corporation, LANXESS, Evonik, and Cytiva among the top companies that are actively shaping the future of the PFAS testing Startups/SMEs Companies Assessment.

MarketsandMarkets Logo

The evaluation leverages 360Quadrants' proprietary methodology to map competitive positioning across 7,000+ micro markets within 10+ industries, enabling decision-makers to make strategic, data-backed vendor choices.

Company Highlights in the PFAS testing Startups/SMEs Companies Assessment:

  • Restek Corporation is a privately held company specializing in the development and manufacturing of high-performance chromatography columns and accessories. Renowned for its innovation and precision, Restek offers a broad portfolio of analytical solutions tailored for the analysis and quality monitoring of air, water, soil, food, pharmaceuticals, chemicals, and petroleum products. In addition to its chromatography products, Restek provides a comprehensive range of certified reference standards that support critical applications in environmental testing, clinical diagnostics, forensic science, toxicology, petrochemical analysis, and pharmaceutical research. Serving laboratories and research institutions around the globe, Restek is widely recognized for delivering reliable, high-quality products that meet the evolving needs of analytical science professionals.
  • Evonik Industries AG, based in Essen, Germany, is a leading global specialty chemicals company known for delivering high-performance materials and innovative solutions across a broad range of industries, including healthcare, nutrition, coatings, agriculture, and energy. With a strong emphasis on sustainability and resource efficiency, Evonik leverages advanced research and development to drive innovation and support environmentally responsible practices. Evonik is actively pursuing the development of sustainable, fluorine-free alternatives. This includes the creation of advanced surfactants, coatings, and additives designed to replace traditional PFAS-based materials, reinforcing the company's commitment to safer, more sustainable chemical solutions.
  • LANXESS is a specialty chemicals company headquartered in Cologne, Germany, established in 2004 as a spin-off from Bayer AG's chemicals division and select polymer operations. With a global presence spanning 32 countries, LANXESS focuses on the development, production, and marketing of high-quality chemical intermediates, additives, and consumer protection products.

To explore the full quadrant report and see how companies are positioned in the PFAS testing Startups/SMEs Companies Assessment, 2025,

Visit: https://www.360quadrants.com/healthcare/pfas-testing-startups

Evaluation Criteria

The vendor evaluation was conducted on over 130 companies, of which the top 10 were categorized and recognized as quadrant leaders. Factors such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the PFAS Testing Startups/Small-Medium Businesses Companies Assessment quadrant. The top criteria for product footprint evaluation included Product (Instruments, consumables, and software & services), Technique (Liquid chromatography with tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS), NMR spectroscopy, mass spectrometry, combustion ion chromatography, enzyme-linked immunosorbent assays (ELISA), and other techniques), and Methods (EPA, DIN, ISO, ASTM, and Other methods), and Application.

360 Quadrants Scoring Methodology

360 Quadrants employs a comprehensive and transparent scoring methodology to evaluate companies. It identifies relevant evaluation criteria, collects and validates data from multiple sources, and employs an algorithm that considers parameter weights to generate scores. Normalization ensures fair comparisons, and the aggregated scores categorize solutions into quadrants such as Progressive companies, Responsive companies, Dynamic companies, and Starting blocks. This unbiased approach equips users with accurate information, empowering them to make well-informed decisions and select solutions that best suit their needs and objectives.

Download Free Sample @https://www.360quadrants.com/healthcare/pfas-testing-startups

About 360Quadrants

360Quadrants, a specialized division of MarketsandMarkets, delivers comprehensive quadrant analyses for various emerging technologies and markets, including start-ups. Our evaluation methodology hinges on two critical parameters: market presence and product footprint. This approach facilitates a graphical representation of competitive positioning across four key categories: leaders, contenders, innovators, and emerging companies. In addition, we meticulously classify start-ups into progressive companies, responsive companies, dynamic companies, and starting blocks. Our expertise equips organizations with insights into market leaders across over 6000 micro markets, enabling a detailed comparison of vendor capabilities and performance. At 360Quadrants, we ensure that each quadrant adheres to the highest standards, empowering our clients to navigate complex market dynamics precisely and confidently.

360Quadrants has also launched quadrants in fields such as -

Material Informatics Startups/SMEs Companies Assessment, 2025, and

Livestock Monitoring Startups/SMEs Companies Assessment, 2025.

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Ms. Sipti Banga,
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sipti.banga@marketsandmarkets.com

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/marketsandmarkets-360quadrants-recognizes-top-startups-and-smes-in-the-pfas-testing-quadrant-report-2025-302475192.html

© 2025 PR Newswire
Gold & Silber auf Rekordjagd
Kaum eine Entwicklung war 2025 so eindrucksvoll wie der Höhenflug der Edelmetalle. Allen voran Silber: Angetrieben von einem strukturellen Angebotsdefizit, explodierte der Preis und übertrumpfte dabei den „großen Bruder“ Gold. Die Nachfrage aus dem Investmentsektor zieht weiter an, und ein Preisziel von 100 US-Dollar rückt in greifbare Nähe.

Auch Gold markierte neue Meilensteine. Mit dem Durchbruch über 3.000 und 4.000 US-Dollar pro Unze hat sich der übergeordnete Aufwärtstrend eindrucksvoll bestätigt. Rücksetzer bleiben möglich, doch der nächste Zielbereich bei 5.000 US-Dollar ist charttechnisch fest im Blick. Die fundamentalen Treiber sind intakt, eine nachhaltige Trendwende aktuell nicht in Sicht.

Für Anlegerinnen und Anleger bedeutet das: Jetzt ist die Zeit, um gezielt auf starke Produzenten zu setzen. In unserem neuen Spezialreport stellen wir fünf Gold- und Silberaktien vor, die trotz Rallye weiter attraktives Potenzial bieten, mit robusten Fundamentaldaten und starken Projekten in aussichtsreichen Regionen.

Jetzt den kostenlosen Report sichern und von der nächsten Welle im Edelmetall-Boom profitieren!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.